Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Apple Inc. (AAPL), Gilead Sciences, Inc. (GILD) & More: Should You Follow Convector Capital’s Top Picks?

Investors are growing bearish on hedge funds due to sloppy performance and high fees, but our research proves that long sides of the smart money’s portfolio always return optimistic gains.  For example, in the third quarter, 627 hedge funds tracked by Insider Monkey which had 5 long positions in companies valued at $1 billion or more returned 8.3% on average, a full 5.0 percentage points more than S&P 500 ETFs. We believe that investors should pay attention to hedge funds’ top picks for a chance to beat the market, and will share four such picks today, courtesy of the 13F portfolio of Convector Capital. These stocks include Gilead Sciences, Inc. (NASDAQ:GILD), Apple Inc. (NASDAQ:AAPL),  Qorvo Inc (NASDAQ:QRVO) and Lumber Liquidators Holdings Inc (NYSE:LL). 

Convector Capital is a New York-based investment firm founded by Emmanuel Ferreira. The fund has an equity portfolio worth $54.46 as of the end of September, down from $72.46 million at the end of June.

Gilead GILD pharmacist store examing pharmaceutical stocks medical

kurhan /

Convector Capital sold 38% of its stake in Gilead Sciences, Inc. (NASDAQ:GILD) during the third quarter, ending the period with 42,928 shares of the company valued at $3.40 million. The move was made as the stock lost 4.6% in the third quarter. At the end of the second quarter, a total of 85 funds tracked by Insider Monkey were long this stock, down by 9% sequentially. Among these funds, Samuel Isaly’s OrbiMed Advisors had the number one position in Gilead Sciences, Inc. (NASDAQ:GILD), worth close to $256.3 million. The second most bullish fund was Cliff Asness’ AQR Capital Management, with a $237.8 million position. Some other members of the smart money that held long positions included Israel Englander’s Millennium Management, John Overdeck and David Siegel’s Two Sigma Advisors, and Phill Gross and Robert Atchinson’s Adage Capital Management.

Follow Gilead Sciences Inc (NASDAQ:GILD)
Trade (NASDAQ:GILD) Now!

Convector Capital had sold 41% of its stake in Apple Inc. (NASDAQ:AAPL) during the second quarter and further cut it by 45% in the following three months amid an 18.9% gain registered by the stock. In this way, the fund held 30,200 shares worth $3.41 million at the end of September. At the end of June, 116 funds from our database were bullish on Apple, down by 24% from the previous quarter. More specifically, Warren Buffett’s Berkshire Hathaway had the number one position in Apple Inc. (NASDAQ:AAPL), worth close to $1.46 billion. On Berkshire Hathaway’s heels was Ken Fisher of Fisher Asset Management, with a $1.0973 billion position. Some other members of the smart money that owned shares of Apple Inc. (NASDAQ:AAPL) included Phill Gross and Robert Atchinson’s Adage Capital Management, David Einhorn’s Greenlight Capital, and Eric W. Mandelblatt’s Soroban Capital Partners.

Follow Apple Inc. (NASDAQ:AAPL)
Trade (NASDAQ:AAPL) Now!

DOWNLOAD FREE REPORT: Warren Buffett's Best Stock Picks

Let Warren Buffett, George Soros, Steve Cohen, and Daniel Loeb WORK FOR YOU.

If you want to beat the low cost index funds by 19 percentage points per year, look no further than our monthly newsletter.In this free report you can find an in-depth analysis of the performance of Warren Buffett's entire historical stock picks. We uncovered Warren Buffett's Best Stock Picks and a way to for Buffett to improve his returns by more than 4 percentage points per year.

Bonus Biotech Stock Pick: You can also find a detailed bonus biotech stock pick that we expect to return more than 50% within 12 months.
Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.